NovaBridge Biosciences Shares Rise After Chairman Pledges to Buy Shares

Dow Jones
01/21
 

By Chris Wack

 

NovaBridge Biosciences shares were 5.4% higher, at $3.93, after the company said Fu Wei, its executive chairman, intends to buy up to $5 million of the company's American depositary shares in open-market transactions.

The biotechnology company said the purchases started Jan. 15, and are ongoing.

NovaBridge said that, as the planned purchases are to be executed by Fu Wei via his controlled entity, the company can't guarantee the number of ADSs to be bought or the time frame in which the ADSs will be bought in the open market.

NovaBridge shares have more than tripled in the past 12 months.

 

Write to Chris Wack at chris.wack@wsj.com

 

(END) Dow Jones Newswires

January 20, 2026 12:40 ET (17:40 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10